Search company, investor...
Diazyme Laboratories company logo

Diazyme Laboratories

diazyme.com

About Diazyme Laboratories

Diazyme Laboratories develops diagnostic reagents for automated chemistry analyzers in user-friendly formats. The company provides test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It is based in Poway, California.

Headquarters Location

12889 Gregg Ct.

Poway, California, 92064,

United States

Missing: Diazyme Laboratories's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Diazyme Laboratories's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Diazyme Laboratories

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Diazyme Laboratories is included in 5 Expert Collections, including Medical Devices.

M

Medical Devices

11,655 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Monitoring & Diagnostics

3,244 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Diabetes

1,899 items

H

Health IT

7,901 items

Diazyme Laboratories Patents

Diazyme Laboratories has filed 1 patent.

The 3 most popular patent topics include:

  • Molecular biology
  • Monoclonal antibodies
  • Androgens and anabolic steroids
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/28/2017

9/6/2022

Monoclonal antibodies, Molecular biology, Immune system, Immunology, Proteins

Grant

Application Date

7/28/2017

Grant Date

9/6/2022

Title

Related Topics

Monoclonal antibodies, Molecular biology, Immune system, Immunology, Proteins

Status

Grant

Latest Diazyme Laboratories News

Glycated Albumin Assay Market size to reach USD 776.5 Million by 2028 | Asahi Kasei, Diazyme Lab, LifeSpan Bio

Nov 16, 2022

| Asahi Kasei, Diazyme Lab, LifeSpan Bio News Provided By Share This Article Glycated Albumin Assay Market SEATTLE, UNITED STATES, UNITED STATES, November 16, 2022 / EINPresswire.com / -- ????The Glycated Albumin Assay market is estimated to be valued at US$ 776.5 million in 2028 and is expected to exhibit a CAGR of 7.7% over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Glycated albumin assay is the amount of a marker directly connected to many serious side-effects of diabetes. It has been exhibited to be a better reflection of the efficiency of therapeutics compared to other trials. It has currently been presented to be an efficient marker to screen for mellitus at an initial stage. Competitive Landscape: Major players included in the global glycated albumin assay market are Geno Technology, Inc., DRG International, Inc., Asahi Kasei Corporation, LifeSpan BioSciences, Inc., Abbexa Ltd.,DxGen Corp., Diazyme Laboratories, Inc., AMS Biotechnology (Europe) Limited, Abnova Corporation, Biomatik Corporation, Ethos Biosciences, Inc., Epinex Diagnostics Inc., and PathShodh Healthcare Private Limited. Get Sample Report of Glycated Albumin Assay Market Report: Key Market Drivers: The increasing number of diabetes cases is expected to boost the growth of the global glycated albumin assay market. As per IDF.Org, around 537 million adults’ ages between 20 years to 80 years are suffering from diabetes in the year 2021 across the globe. Rising approval of inorganic growth plans such as collaborations and acquisitions by market players is projected to propel growth of the global glycated albumin assay market. For example, in July 2018, Asahi Kasei Corporation signed a MoU with Stanbio Laboratory, L.P for promoting of Lucica GA-L in the U.S. Covid-19 Impact Analysis: The Covid-19 outbreak had led to an adverse impact on the growth of global Glycated Albumin Assay market due to the strict imposition of shut down and lockdown by the regulatory and moreover, the spread of virus had led to the restrictions in movement of people from one place to other and also visits to the hospitals for regular check-up had led to the decline in market growth. ⏩ Glycated Albumin Assay Market Segmentation: By Product Type: 2] Who are the potential customers of the Glycated Albumin Assay Market? 3] How can I get a report sample of the Glycated Albumin Assay Market? 4] What are the key trends in Glycated Albumin Assay Market? 5] Who are the leading players in Glycated Albumin Assay Market? 6] How can I get statistical data on the top market players in the Glycated Albumin Assay Market? 7] Which segment holds the maximum share of the Glycated Albumin Assay Market? 8] What is the total market value of the Glycated Albumin Assay Market? 9] What is the CAGR of the Glycated Albumin Assay Market? Purchase this report (Up to 40% Discount):

Diazyme Laboratories Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Diazyme Laboratories Rank

Diazyme Laboratories Frequently Asked Questions (FAQ)

  • Where is Diazyme Laboratories's headquarters?

    Diazyme Laboratories's headquarters is located at 12889 Gregg Ct., Poway.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.